Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside

Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside

Type 1 diabetes (T1D) is a chronic metabolic disease characterized by insulin deficiency, generally resulting from progressive autoimmune-mediated destruction of pancreatic beta cells. While the phenomenon of beta cell autoimmunity continues to be an active area of investigation, recent evidence sug...

Full description

Bibliographic Details
Main Authors: Gabriel Brawerman, Peter J. Thompson
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Biomolecules
Subjects:
pancreatic beta cells
type 1 diabetes
apoptosis
senescence
immunotherapy
Online Access:https://www.mdpi.com/2218-273X/10/12/1681

Similar Items

Similar Items